PPIDT00231

Drug Information
NameAprotinin
SequenceRPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA
DrugBank_IDDB06692
Typebiotech
IndicationFor prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the course of coronary artery bypass graft surgery who are at an increased risk for blood loss and blood transfusion.

Dosage Forms
Form Route Strength
Solution Topical
Solution Topical
360 -
Solution
Powder, for solution Topical
Kit Topical
Powder Topical
Kit; solution
Solution Topical
3000 KIU/ml
Powder Soft tissue
Solution Intravenous
10000 unit / mL
Solution Intravenous
1000000 1/100mL
Solution Intravenous
2000000 1/200mL
Solution Intravenous
10000 KIE/ml
Liquid Intravenous
100000 unit / amp
Injection Intravenous
500000 kiu/50ml
Target Information
Role Uniprot_ID Gene_Name Entity_Name Organism Actions Internal link
target P07477 PRSS1 Serine protease 1 Homo sapiens unknown Link
target P17538 CTRB1 Chymotrypsinogen B Homo sapiens unknown Link
target P00747 PLG Plasminogen Homo sapiens unknown Link
target P06870 KLK1 Kallikrein-1 Homo sapiens unknown Link
enzyme P06276 BCHE Cholinesterase Homo sapiens inhibitor Link